You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 November 2025 - Norwegian biotechnology company Hemispherian AS announced on Wednesday that the US Patent and Trademark Office has issued a Notice of Allowance for its patent application covering use of its lead clinical candidate, GLIX1, in cance...
19 November 2025 - BioNet, a biotechnology company developing and manufacturing next generation vaccines including recombinant and mRNA vaccines, announced on Tuesday that it has received positive opinion from the Committee for Medicinal Products for...
19 November 2025 - Aetna, a CVS Health company (NYSE:CVS), announced on Tuesday that it is introducing a generative AI-powered conversational experience in its digital channels designed to simplify healthcare.This offering will allow members to quick...
19 November 2025 - US-based pharmaceutical company AbbVie (NYSE:ABBV) announced on Tuesday that it has received approval from the US Food and Drug Administration for EPKINLY (epcoritamab-bysp), a T-cell engaging bispecific antibody administered subcu...
19 November 2025 - Sweden-based biotics solutions company Probi, a subsidiary of German chemicals company Symrise AG (ETR: SY1), announced on Wednesday that it has expanded its portfolio with two new categories: Sports & Active Nutrition by Probi...
18 November 2025 - US-based biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) said on Tuesday that the European Commission has approved BRINSUPRI (brensocatib 25mg tablets) for patients with non-cystic fibrosis bronchiectasis aged 12 and o...
18 November 2025 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Tuesday that its Phase III lidERA trial of giredestrant met its primary endpoint in early-stage ER-positive, HER2-negative bre...